Has Walid Baz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,053 in general payments to Walid Baz, MD across 50 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Walid Baz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Walid Baz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Walid Baz, MD

Hematology & Oncology · South Williamson, KYNPI 1487970653

Payments from drug & device makers

$1,053in general payments, 2019–2025

Across 50 payments — averaging $21.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Daiichi Sankyo Inc.$746
Novartis$103
E.r. Squibb & Sons, L.L.C.$100
Pfizer$32
AstraZeneca$28
Lilly USA, LLC$15
plus $29 from 2 others

What the payments were for

Food & beverage$1,03798%
Education$162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Daiichi Sankyo Inc.	39	$746
Novartis	2	$103
E.r. Squibb & Sons, L.L.C.	2	$100
Pfizer	2	$32
AstraZeneca	2	$28
Lilly USA, LLC	1	$15
Paratek Pharmaceuticals, Inc.	1	$15
AbbVie	1	$14

How this compares

$1,053 in reported general payments places this provider in the 15th percentile of 143 hematology & oncology providers in Kentucky.

See all hematology & oncology providers in Kentucky →

Medicare billing

Part B allowed, 2024

$20,316

Medicare patients

Services billed

207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RevlimidLenalidomide	11	$197,028
AvastinBevacizumab	17	$59,930
ProcritEpoetin Alfa	24	$19,794
Abiraterone Acetate	11	$6,187
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	29	$738
Imatinib Mesylate	13	$691
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	12	$316
Hydroxyurea	19	$299
Dexamethasone	17	$278
Ondansetron OdtOndansetron	14	$238
Anastrozole	25	$165
Acyclovir	14	$157
Potassium Chloride	19	$109
Prednisone	14	$40

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in South Williamson

Joseph MalyLouisville$7M
Firas BadinLexington$6.7M
Laila AgrawalLouisville$6.3M
Jaspreet GrewalLouisville$4.2M
John VillanoLexington$3.2M
Rebecca RedmanLouisville$2.1M
Vivek SharmaLouisville$1.9M
Rohit KumarLouisville$1.6M
Miguel Islas-OhlmayerEdgewood$1.6M
Jeffrey HargisLouisville$1.3M

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →